Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Calidi Biotherapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 24.1× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −18.2 |
| 2025 | Dec 31, 2025 | 18.7× | – |
See a number that looks wrong?